Get an alert when TICTRAC LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-07-29 (in 2mo)

Last made up 2025-07-15

Watchouts

None on the register

Cash

£96K

-91.3% vs 2021

Net assets

-£2M

-252.3% vs 2021

Employees

22

-26.7% vs 2021

Profit before tax

Period ending 2022-12-31

Accounts

6-year trend · latest reflected 2022-12-31

Latest accounts filed cover 2024-12-31; financial figures currently reflect up to 2022-12-31.

Metric Trend 2019-01-012019-12-312020-01-012020-12-312021-12-312022-12-31
Turnover
Operating profit
Profit before tax
Net profit -£1,752,284-£3,769,823
Cash £80,842£1,107,399£96,327
Total assets less current liabilities -£7,565,994£1,500,040-£2,268,860
Net assets -£7,571,764£1,493,755-£2,274,425
Equity -£5,689,489-£7,571,764£4,093,167£1,493,755-£2,274,425
Average employees 223022
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Grant Thornton UK LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The company made a profit before tax for the year ended 31 December 2024 of £3,501,063 (2023: profit of £4,033,963) with cash of £546,487 (2023: £209,803) at the year end. Dialogue Health Technologies Inc. ("the immediate parent") is the immediate parent company of Tictrac Limited and has issued a letter of financial support to Tictrac Limited for the 12 months after the approval of the financial statements. The immediate parent, Dialogue Health Technologies Inc, has confirmed that it will continue to financially support the company for at least 12 months, from the date of approval of the statutory financial statements for the year ended 31 December 2024 to enable it to meet its liabilities as they fall due. The company has demonstrated its ability to meet all of its obligations at the Statement of Financial Position date, even without considering the receivable from Dialogue Health Technologies Inc. By including the receivable from Dialogue Health Technologies Inc, the company gains additional resources that will allow it to operate for the next 12 months. Additionally, the immediate parent has confirmed its capacity to provide financial support if required. This assurance takes into account potential scenarios where the company might face financial difficulties and require additional funding to continue operations. Therefore, the directors continue to adopt the going concern basis of preparation.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 14 resigned

Name Role Appointed Born Nationality
BACKHOUSE, Christopher Mark Director 2024-11-29 Aug 1957 British
MANSURI, Navaid Director 2022-04-30 Nov 1972 Canadian
MINER, Richard Director 2024-11-29 Mar 1960 British
Show 14 resigned officers
Name Role Appointed Resigned
BLINDER ACENAL, Luis Martin Secretary 2010-10-07 2023-09-01
CC SECRETARIES LIMITED Corporate Secretary 2014-06-10 2014-06-10
CC SECRETARIES LIMITED Corporate Secretary 2012-12-21 2025-09-19
BLINDER ACENAL, Luis Martin Director 2010-10-07 2023-09-01
DELISLE, Nathalie Director 2022-04-30 2023-03-22
DOUMENG, Jean-Philippe Director 2015-05-21 2016-11-20
HALL II, James Larry Director 2017-05-16 2019-11-05
HAUPT, Ludwig Michael Director 2011-12-12 2022-04-30
HEYWOOD JONES, Benjamin John Director 2023-08-30 2024-01-29
MACCARTHY, Oliver James Director 2011-07-12 2022-04-30
NAOURI, Gabriel Director 2012-08-24 2022-04-30
NOBLE, Mark Andrew Director 2019-06-01 2022-04-30
POPE, Edward Robert Director 2017-02-21 2019-05-20
WEST, Alexander Rupert Director 2020-03-23 2022-04-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Mr Luis Martin Blinder Acenal Individual Shares 25–50%, Voting 25–50% 2016-04-06 Ceased 2020-03-23
Mr Oliver James Maccarthy Individual Shares 25–50%, Voting 25–50% 2016-04-06 Ceased 2020-03-23

Filing timeline

Last 20 of 117 total filings

Date Type Category Description
2025-10-04 AA accounts Accounts with accounts type full
2025-09-24 CH01 officers Change person director company with change date PDF
2025-09-19 CH01 officers Change person director company with change date PDF
2025-09-19 CH01 officers Change person director company with change date PDF
2025-09-19 TM02 officers Termination secretary company with name termination date PDF
2025-09-19 AD01 address Change registered office address company with date old address new address PDF
2025-07-17 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-12-17 AA accounts Accounts with accounts type full
2024-11-29 AP01 officers Appoint person director company with name date PDF
2024-11-29 AP01 officers Appoint person director company with name date PDF
2024-07-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-15 CH01 officers Change person director company with change date PDF
2024-03-19 AA accounts Accounts with accounts type group PDF
2024-03-16 DISS40 gazette Gazette filings brought up to date
2024-03-12 GAZ1 gazette Gazette notice compulsory
2024-01-29 TM01 officers Termination director company with name termination date PDF
2023-09-12 AP01 officers Appoint person director company with name date PDF
2023-09-04 TM02 officers Termination secretary company with name termination date PDF
2023-09-04 TM01 officers Termination director company with name termination date PDF
2023-07-25 CS01 confirmation-statement Confirmation statement with no updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
7

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2021 → FY2022 · period ending 2022-12-31 vs 2021-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page